Factors Influencing the Development of Lipodystrophy in Human Immunodeficiency Virus-infected Patients
- 1 May 2003
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 35 (5) , 339-340
- https://doi.org/10.1080/00365540310008393
Abstract
238 human immunodeficiency virus-infected patients on highly active antiretroviral therapy (HAART) were studied, 67 of whom (28.2%) developed lipodystrophy. The presence of hyperlipidaemia (p = 0.002) and of hepatitis C virus coinfection (p = 0.014) were associated with lipodystrophy, but only the duration of HAART was significantly predictive of lipodystrophy (p < 0.0001) in the multivariate analysis.Keywords
This publication has 5 references indexed in Scilit:
- Hepatitis C Virus in Patients With HIV Infection and LipodystrophyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Factors Related to Lipodystrophy and Metabolic Alterations in Patients with Human Immunodeficiency Virus Infection Receiving Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2002
- Association Between Insulin Resistance and Hepatitis C Virus Chronic Infection in HIV–Hepatitis C Virus–Coinfected Patients Undergoing Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapyAIDS, 1999